Arianna Loregian

Padova, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications

Streamlined Synthesis and Structure-Activity Relationship Analysis of 2-Amidothiophene-3-Carboxamides Targeting Influenza Polymerase PA-PB1 Heterodimerization.

Streamlined Synthesis and Structure-Activity Relationship Analysis of 2-Amidothiophene-3-Carboxamides Targeting Influenza Polymerase PA-PB1 Heterodimerization.

Journal: ChemMedChem
Published: March 30, 2026

Rationally optimized mucroporin-M1 peptides disrupt viral envelopes and resist degradation.

Rationally optimized mucroporin-M1 peptides disrupt viral envelopes and resist degradation.

Journal: Bioorganic chemistry
Published: March 27, 2026

Recent Advances in Antiviral Medicinal Chemistry against Flaviviruses Driven by Multistrategic Approaches.

Recent Advances in Antiviral Medicinal Chemistry against Flaviviruses Driven by Multistrategic Approaches.

Journal: Journal of medicinal chemistry
Published: February 26, 2026

Synthesis and Evaluation of Aromatic Sulfonamide and Disulfonamide Derivatives as Dengue Virus NS3-NS5 Interaction Inhibitors.

Synthesis and Evaluation of Aromatic Sulfonamide and Disulfonamide Derivatives as Dengue Virus NS3-NS5 Interaction Inhibitors.

Journal: ChemMedChem
Published: February 18, 2026

Discovery of a tetrahydrobenzothiophen-2-yl-pyrazolo[1,5-a]pyrimidine-3-carboxamide-based PROTAC as degrader of SARS-CoV-2 main protease.

Discovery of a tetrahydrobenzothiophen-2-yl-pyrazolo[1,5-a]pyrimidine-3-carboxamide-based PROTAC as degrader of SARS-CoV-2 main protease.

Journal: European journal of medicinal chemistry
Published: December 30, 2025

New Insights into Pathogenesis and Management of Keratoacanthoma: A Narrative Review.

New Insights into Pathogenesis and Management of Keratoacanthoma: A Narrative Review.

Journal: International journal of molecular sciences
Published: August 20, 2025

New dengue virus inhibitors targeting NS3-NS5 interaction identified by in silico screening.

New dengue virus inhibitors targeting NS3-NS5 interaction identified by in silico screening.

Journal: Frontiers in microbiology
Published: July 10, 2025

PROteolysis TArgeting Chimeras (PROTACs) and beyond: targeted degradation as a new path to fight microbial pathogens.

PROteolysis TArgeting Chimeras (PROTACs) and beyond: targeted degradation as a new path to fight microbial pathogens.

Journal: FEMS microbiology reviews
Published: April 17, 2025

Letermovir shows antiviral and neuroprotective effects in differentiating neurons and cerebral organoids mimicking human developing brain.

Letermovir shows antiviral and neuroprotective effects in differentiating neurons and cerebral organoids mimicking human developing brain.

Journal: Cellular and molecular life sciences : CMLS
Published: April 11, 2025

Novel SARS-CoV-2 allosteric inhibitors that destabilize the Main Protease Mpro dimer.

Novel SARS-CoV-2 allosteric inhibitors that destabilize the Main Protease Mpro dimer.

Journal: International journal of biological macromolecules
Published: February 27, 2025

Antiviral drug repurposing: different approaches and the case of antifungal drugs.

Antiviral drug repurposing: different approaches and the case of antifungal drugs.

Journal: Pharmacology & therapeutics
Published: January 11, 2025

Elaborate Structural Modifications Yielding Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Potent Neuraminidase Inhibitors with Significantly Improved Broad-Spectrum Antiresistance Profiles.

Elaborate Structural Modifications Yielding Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Potent Neuraminidase Inhibitors with Significantly Improved Broad-Spectrum Antiresistance Profiles.

Journal: Journal of medicinal chemistry
Published: December 07, 2024
Showing 1-12 of 86

Last Updated: 09/26/2026